Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trial
Authors
Jian‐Kun Hu (ORCID: https://orcid.org/0000-0002-3294-3471)
Du He (ORCID: https://orcid.org/0000-0002-6358-3130)
Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trial
Jian‐Kun Hu, Du He, Hongfeng Gou, Xi-Jiao Liu et al.
Citations
2 citations
Journal
BMJ Open
Topics
Gastric Cancer Management and Outcomes
Field-Weighted Citation Impact (FWCI)
0.84
article
Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trial
Jian‐Kun Hu, Du He, Hongfeng Gou, Xi-Jiao Liu, Kun Yang, Peng-Fei Zhang, Wei-Han Zhang
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 14(12)
Institutions
Sichuan University (CN), West China Hospital of Sichuan University (CN), Sichuan Cancer Hospital (CN), State Key Laboratory of Biotherapy
Funders
Sichuan University, West China Hospital, Sichuan University